europhenomenology of Deep Brain Stimulation for Depressio

• Conditions: F33.2; F33.3; F33.8; F33.9; Recurrent depressive disorder, current episode severe without psychotic symptoms; Recurrent depressive disorder, current episode severe with psychotic symptoms; Other recurrent depressive disorders; Recurrent depressive disorder, unspecified

• Registration Number: DRKS00016688
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

A variety of qualitative insights into the effects of DBS were gained. For a summary, see the reporting sheet. The complete results of the interviews in the form of the bachelor’s thesis that was the result of the project can be made available upon request to the student that performed the project: Lucca-jaeckel@gmx.de

Detailed Description

Not available

Study Timeline

• Study Start: 2019-04-01
• Study Completion: 2019-04-15
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

Participation one of the following clinical trials assessing the efficacy of deep brain stimulation for depression: FORESEE (ClinicalTrials.gov NCT01095263), FORESEE II (ClinicalTrials.gov NCT01778790), FORESEE III (ClinicalTrials.gov NCT03653858); Active treatment with DBS over the duration of at least 2 weeks

Exclusion Criteria

Acute psychotic or manic episode

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The study aims to obtain qualitative data, to assess the phenomenology of deep brain stimulation for depression after a treatment duration of at least 2 weeks.